{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:35:24Z","timestamp":1768084524291,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.brachy.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T14:00:49Z","timestamp":1502200849000},"page":"1169-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-334X","authenticated-orcid":false,"given":"\u00c1ngeles","family":"Rovirosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ascaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stepphania","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9540","authenticated-orcid":false,"given":"Sebasti\u00e0","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aureli","family":"Torn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.07.003_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12094-012-0794-2","article-title":"Consensus on treatment of endometrium carcinoma with brachytherapy of SEOR and SEFM brachytherapy group","volume":"14","author":"Guinot","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American brachytherapy society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib3","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2016.06.012","article-title":"Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data","volume":"15","author":"Modh","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2015.09.084","article-title":"Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer","volume":"140","author":"Mitra","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib7","article-title":"Libro de braquiterapia 3D guiada por la Imagen de la Sociedad Espa\u00f1ola de Oncolog\u00eda Radioter\u00e1pica (SEOR)","author":"Rovirosa","year":"2017"},{"key":"10.1016\/j.brachy.2017.07.003_bib8","series-title":"The GEC ESTRO Handbook of Brachytherapy | Part II: Clinical Practice","article-title":"Endometrial cancer","author":"Hoskin","year":"2017"},{"key":"10.1016\/j.brachy.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0360-3016(00)00689-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.003_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2007.03.024","article-title":"External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer","volume":"106","author":"Lin","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brachy.2011.05.004","article-title":"Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer","volume":"11","author":"Gazta\u223cnaga","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2005.04.038","article-title":"American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: Current status of vaginal brachytherapy","volume":"63","author":"Small","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.003_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijrobp.2010.06.001","article-title":"Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma","volume":"8","author":"Rovirosa","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2015.06.016","article-title":"Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules","volume":"116","author":"Rovirosa","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2016.10.001","article-title":"A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results","volume":"16","author":"Rovirosa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib18","unstructured":"SRCTN11659025 DOI 10.1186\/ISRCTN11659025."},{"key":"10.1016\/j.brachy.2017.07.003_bib19","first-page":"602","article-title":"Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity","volume":"15","author":"Valduvieco","year":"2013","journal-title":"Clin\u00a0Transl Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12094-015-1463-z","article-title":"Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients","volume":"18","author":"R\u0131os","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib21","unstructured":"ICRU Report no. 38, dose and volume specification for reporting intracavitary therapy in gynaecology. In: Chassagne D, Dutreix A, Almond P, et\u00a0al, editors. International commissioning on radiation units and measurements, 1985. Bethesda, MD. Available at: http:\/\/icru.org\/icru-news\/page-10."},{"key":"10.1016\/j.brachy.2017.07.003_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0167-8140(95)01548-U","article-title":"Late effects consensus conference RTOG\/EORTC","volume":"35","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0360-3016(95)90159-0","article-title":"LENT SOMA scales for all anatomic sites","volume":"31","year":"1995","journal-title":"Int J Radiat Oncol Phys"},{"key":"10.1016\/j.brachy.2017.07.003_bib24","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. (v4.03: June 14, 2010)","year":"2009"},{"key":"10.1016\/j.brachy.2017.07.003_bib25","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomized Post-Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5114\/jcb.2016.64511","article-title":"Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit?","volume":"8","author":"Laliscia","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brachy.2015.10.010","article-title":"Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I\u2013II endometrial cancer: A monoinstitutional experience","volume":"15","author":"Perrucci","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib28","first-page":"S964","article-title":"Postoperative endometrium: 68Gy EQD2(\u03b1\/\u03b2=3) at 2cc of vagina\u00a0is related to G2 late toxicity","volume":"123","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.07.003_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/jcb.2015.48539","article-title":"7Gyx2\u2013An effective treatment regime for stage I-II uterine papillary serous","volume":"7","author":"Damast","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.07.003_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0000000000000376","article-title":"Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: Analysis of outcomes and patterns of recurrence based on pathologic characteristics","volume":"25","author":"Young","year":"2015","journal-title":"Int J Gynecol Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:11:59Z","timestamp":1761531119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117304038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1538472117304038"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.07.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}